Ipca Laboratories Limited

Ipca Laboratories Limited (India) holds 52 active US FDA Type II Drug Master Files and 54 inactive, has DMF or CEP filings on record for 40 active ingredients and is linked to 7 FDA-registered manufacturing sites. 20 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Ipca Laboratories Limited: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/ipca-laboratories-limited

Overview

Ipca Laboratories Limited is a leading Indian pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical formulations, active pharmaceutical ingredients (APIs), and intermediates. The company is well-regarded for its therapeutic expertise in areas such as rheumatology, cardiology, dermatology, and anti-malarials.

Core services & business areas

Pharmaceutical ManufacturingAPI ProductionFormulation

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Ipca Laboratories Limited holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Ipca Laboratories Limited holds 52 active (106 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • IMIPRAMINE HYDROCHLORIDE USPActive2026-07-28
  • ATOVAQUONE USPActive2025-07-29
  • TRAZODONE HYDROCHLORIDE USPActive2025-02-28
  • FLUOXETINE HYDROCHLORIDE USPActive2024-12-13
  • LOSARTAN POTASSIUM USP (LB4 PROCESS)Active2024-10-30
  • DULOXETINE HYDROCHLORIDE USPActive2024-07-31
  • BUPROPION HYDROCHLORIDE USPActive2024-06-28
  • MELOXICAM USPActive2022-11-02
  • OLANZAPINE USPActive2022-07-14
  • HYDROXYZINE PAMOATE USPActive2022-03-31
  • VENLAFAXINE HYDROCHLORIDE USPActive2017-07-03
  • VALSARTAN USPActive2016-03-31
  • TELMISARTAN USPActive2014-03-12
  • CHLORTHALIDONE USP (CT6 PROCESS)Active2013-09-30
  • ETODOLAC USP (ED7 PROCESS)Active2013-09-21
  • MIDODRINE HYDROCHLORIDE USPActive2013-09-18
  • BISOPROLOL FUMARATE USP (PROCESS II)Active2013-08-12
  • RISEDRONATE SODIUM HEMI-PENTAHYDRATE USPActive2013-07-17
  • CETIRIZINE HYDROCHLORIDE USP (CZ5 PROCESS)Active2012-05-23
  • TRIMETHOPRIM USPActive2012-03-27
  • PRIMAQUINE PHOSPHATE USPActive2011-10-11
  • ETODOLAC USP (ED6 PROCESS)Active2011-05-02
  • TORSEMIDE USPActive2010-09-15
  • ONDANSETRON USPActive2010-08-18
  • AMLODIPINE BESYLATE USPActive2010-07-30
  • HYDROXYZINE HYDROCHLORIDE USPActive2010-04-09
  • MESALAMINE USP (PROCESS II)Active2010-04-03
  • RISPERIDONE USPActive2009-07-15
  • PYRIMETHAMINE USPActive2009-06-26
  • WARFARIN SODIUM CLATHRATE USPActive2008-08-12
  • ALLOPURINOL USPActive2008-07-25
  • PROGUANIL HYDROCHLORIDE USPActive2008-06-16
  • METOPROLOL TARTRATE USP (PROCESS III)Active2008-02-07
  • QUETIAPINE FUMARATEActive2007-12-14
  • ALENDRONATE SODIUM USPActive2007-12-03
  • CARVEDILOL USPActive2007-10-18
  • ONDANSETRON HYDROCHLORIDE USPActive2007-08-20
  • GLIMEPIRIDE USPActive2006-12-19
  • METFORMIN HYDROCHLORIDE USP (PROCESS-II)Active2006-11-20
  • METOPROLOL SUCCINATE USP (PROCESS-II)Active2006-08-24
  • HYDROCHLOROTHIAZIDE USP, PROCESS IIActive2005-11-11
  • CHLORTHALIDONE USPActive2004-11-03
  • HYDROCHLOROTHIAZIDE USPActive2003-07-07
  • METOPROLOL TARTRATE USPActive2002-02-02
  • PROPRANOLOL HYDROCHLORIDE USPActive2002-02-01
  • ATENOLOL USPActive2000-09-08
  • HYDROXYCHLOROQUINE SULFATE USPActive1999-04-17
  • FUROSEMIDE USPActive1993-02-23
  • PROBENECID USPActive1991-07-02
  • CHLOROQUINE PHOSPHATE USPActive1991-07-02

Showing the 50 most relevant of 106 Drug Master Files (active first). The full list is in the FDA DMF list.

Registered manufacturing sites (7)

Physical sites registered with the US FDA and resolved to Ipca Laboratories Limited, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

20 FDA enforcement records linked to this company.

  • 4832019-08-23

    Deviations from laboratory control requirements

  • 4832019-08-23

    Investigations of discrepancies, failures

  • 4832019-08-23

    Procedures not in writing, fully followed

  • 4832017-03-08

    Timely submission

  • 4832017-03-08

    Failure to develop written procedures

  • warning_letter2016-01-29

    FDA Warning Letter (drug product)

  • warning_letter2016-01-29

    FDA Warning Letter (drug product)

  • warning_letter2016-01-29

    FDA Warning Letter (drug product)

  • 4832013-04-26

    Written program not followed

  • 4832013-04-26

    Second person sign off

  • 4832013-04-26

    Calculations performed are in the records

  • 4832010-05-28

    Complaint Handling Procedure

  • 4832010-05-28

    Manufacturing Instructions and Specifications

  • 4832010-05-28

    Review of representative number of batches

  • 4832010-05-28

    Adverse Drug Experience

  • 4832010-05-28

    Scientifically sound laboratory controls

  • 4832010-05-28

    Procedure Deviations Recorded and Justified

  • 4832010-05-28

    Batch production and Batch Control Record Requirements

  • 4832010-05-28

    Cleaning SOPs/instructions

  • 4832010-05-28

    In-process materials specifications

For suppliers

Is this Ipca Laboratories Limited?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.